Try our beta test site
125 studies found for:    Open Studies | "Shock, Septic"
Show Display Options
Rank Status Study
21 Not yet recruiting Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
Condition: Septic Shock
Intervention: Biological: blood sampling
22 Recruiting The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
Condition: Septic Shock
Interventions: Drug: Daptomycin;   Other: determination of plasma concentration
23 Not yet recruiting Effects of Administration of Mesenchymal Stem Cells on Organ Failure During the Septic Shock
Condition: Septic Shock
Interventions: Biological: Injection of mesenchymal stem cells;   Biological: Injection of albumin alone
24 Recruiting Effects of Levosimendan on Cellular Metabolic Alterations in Patients With Septic Shock
Condition: Septic Shock
Interventions: Device: Microdialysis Probe (Muscle microdialysis);   Drug: Dobutamine;   Drug: Levosimendan
25 Recruiting A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of Outcome
Condition: Septic Shock
26 Recruiting Effects of Continuous Haemofiltration vs Intermittent Haemodialysis on Microcirculatory Parameters in Septic Shock
Condition: Septic Shock
Intervention: Device: muscle microdialysis
27 Recruiting Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
Condition: Immunology of Septic Shock
Intervention: Other: Circulating blood (leukocytes)
28 Recruiting Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)
Condition: Septic Shock
Interventions: Drug: OctaplasLG®;   Drug: Ringer-acetat
29 Recruiting Balanced Salt Solution VS. Normal Saline Solution in Septic Shock
Conditions: Shock, Septic;   Sepsis
Interventions: Drug: Ringer acetate;   Drug: Normal saline
30 Recruiting Microcirculation After MAP Increase in Septic Shock Patients With Previous Hypertension
Condition: Septic Shock
Intervention: Drug: norepinephrine
31 Recruiting ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock
Condition: Septic Shock
Interventions: Drug: Hydrocortisone;   Drug: Sterile air filled vial
32 Recruiting What Should be the Next Vasopressor for Severe Septic Shock? Methylene Blue or Terlipressin
Conditions: Septic Shock;   Refractory Shock
Interventions: Drug: Methylene Blue;   Drug: Terlipressin
33 Not yet recruiting Propafenone Versus Amiodarone in Septic Shock
Conditions: Supraventricular Arrhythmia;   Septic Shock
Interventions: Drug: Propafenone i.v.;   Drug: Amiodarone i.v.
34 Recruiting ICU Echocardiography in Septic Shock
Conditions: Septic Shock;   Severe Sepsis
Intervention: Other: Echocardiography
35 Not yet recruiting Balanced Salt Solutions vs. Normal Saline in Children With Septic Shock
Conditions: Septic Shock;   Shock
Interventions: Drug: Balanced salt solution;   Drug: Normal saline
36 Recruiting Early Use of Norepinephrine in Septic Shock Resuscitation
Conditions: Septic Shock;   Severe Sepsis
Interventions: Drug: Early norepinephrine;   Drug: Placebo
37 Not yet recruiting Observational Study on Intubation in Septic Shock
Condition: Septic Shock
38 Recruiting Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.
Conditions: Septic Shock;   Adult
Interventions: Drug: hydrocortison hemisuccinate;   Drug: placebo followed by hydrocortisone hemisuccinate
39 Recruiting Dex on Microcirculation in SS—A Double-blinded Study
Condition: Septic Shock
Intervention: Drug: Dexmedetomidine for dexmedetomidine group
40 Recruiting Methylene Blue in Severe Sepsis and Septic Shock
Conditions: Severe Sepsis;   Septic Shock
Interventions: Drug: Intravenous methylene blue administration;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.